The successful formation of Sanofi-Aventis has brought Sanofi-Synthelabo (M) and Aventis Farma SA (M) Sdn Bhd (including Sanofi Pasteur) to an integrated operation in Malaysia under one roof.

The sanofi-aventis Group is the world’s 3rd largest pharmaceutical company, ranking number 1 in Europe.   Backed by a world-class R&D organization, sanofi-aventis is developing leading positions in seven major therapeutic areas: cardiovascular disease, thrombosis, oncology, diabetes, central nervous system, internal medicine and vaccines.